Quantitation using TCR network analysis (Figure 1G) further corroborated that cytotoxic CD4+ (GZMB+ and GZMK+) T cells were significantly overrepresented in clusters of tumor-blood matched TCRs over nonmatched TCRs in blood and tumor (Figure 2B and Supplemental Dataset 7). The gene discussed is CD4; the disease is neoplasm.